英科医疗：关于2022年限制性股票激励计划第三期解除限售条件成就的公告

Core Viewpoint - The announcement from Yingke Medical regarding the approval of the third phase of the restricted stock incentive plan indicates a significant step in the company's employee incentive strategy, potentially enhancing employee motivation and retention [1] Summary by Relevant Sections - Incentive Plan Details - The company held its fourth board meeting on October 20, 2025, where it approved the resolution concerning the achievement of conditions for the third phase of the 2022 restricted stock incentive plan [1] - A total of 540 individuals are eligible for the release of restrictions, with 1,052,520 shares being released, which represents 0.1607% of the company's total share capital [1] - Future Actions - Following the completion of the release procedures, the company will issue a related announcement regarding the listing and circulation of the released shares, urging investors to pay attention [1]